BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8963039)

  • 1. Primary liver cancer is of multifactorial origin: importance of hepatitis B virus infection and dietary aflatoxin.
    Saracco G
    J Gastroenterol Hepatol; 1995; 10(5):604-8. PubMed ID: 8963039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aflatoxins as risk factors for hepatocellular carcinoma in humans.
    Wogan GN
    Cancer Res; 1992 Apr; 52(7 Suppl):2114s-2118s. PubMed ID: 1311989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: a molecular epidemiological approach.
    Sylla A; Diallo MS; Castegnaro J; Wild CP
    Mutat Res; 1999 Jul; 428(1-2):187-96. PubMed ID: 10517992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive effects of chemical carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.
    Harris CC; Sun TT
    Cancer Surv; 1986; 5(4):765-80. PubMed ID: 3040243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma: from gene to public health.
    Montesano R; Hainaut P; Wild CP
    J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of chemicals on liver cancer risk.
    Wogan GN
    Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflatoxin, hepatitis and worldwide liver cancer risks.
    Henry SH; Bosch FX; Bowers JC
    Adv Exp Med Biol; 2002; 504():229-33. PubMed ID: 11922091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.
    Wild CP; Jansen LA; Cova L; Montesano R
    Environ Health Perspect; 1993 Mar; 99():115-22. PubMed ID: 8391433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma.
    Ayoola EA
    IARC Sci Publ; 1984; (63):167-79. PubMed ID: 6100268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention.
    Wild CP; Montesano R
    Cancer Lett; 2009 Dec; 286(1):22-8. PubMed ID: 19345001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya.
    Autrup H; Seremet T; Wakhisi J; Wasunna A
    Cancer Res; 1987 Jul; 47(13):3430-3. PubMed ID: 3034416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment for aflatoxin: an evaluation based on the multistage model.
    Bowers J; Brown B; Springer J; Tollefson L; Lorentzen R; Henry S
    Risk Anal; 1993 Dec; 13(6):637-42. PubMed ID: 8310162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland.
    Peers F; Bosch X; Kaldor J; Linsell A; Pluijmen M
    Int J Cancer; 1987 May; 39(5):545-53. PubMed ID: 3570547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary risk factors for primary hepatocellular carcinoma.
    Wogan GN
    Cancer Detect Prev; 1989; 14(2):209-13. PubMed ID: 2559796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
    Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aflatoxin is not a probably human carcinogen: the published evidence is sufficient.
    Stoloff L
    Regul Toxicol Pharmacol; 1989 Dec; 10(3):272-83. PubMed ID: 2690197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aflatoxin, viral hepatitis and primary liver cancer.
    Stora C; Dvorackova I
    J Med; 1987; 18(1):23-41. PubMed ID: 3036991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand. A correlation study.
    Srivatanakul P; Parkin DM; Jiang YZ; Khlat M; Kao-Ian UT; Sontipong S; Wild C
    Cancer; 1991 Dec; 68(11):2411-7. PubMed ID: 1657355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.